Position in ALKS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,347,348
+$672,062 QoQ
Shares Held
44,801
-5.4% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#163
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMALGAMATED BANK holds $48,279,531 across 17 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
19,387 | $10,504,458 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
48,241 | $8,130,538 | |
| 3 | ZTS |
Zoetis Inc.
|
84,819 | $6,095,093 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
220,819 | $5,434,355 | |
| 5 | VTRS |
Viatris Inc
|
203,598 | $3,233,136 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
90,088 | $3,123,350 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
27,649 | $3,067,380 | |
| 8 | ALKS |
Alkermes plc.
This page
|
44,801 | $2,347,348 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,347,348 | 44,801 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,675,286 | 47,378 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,339,542 | 47,875 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,413,390 | 47,113 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,340,321 | 46,848 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,529,486 | 46,320 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,365,352 | 47,474 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,361,797 | 48,653 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,243,246 | 51,587 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,409,291 | 52,061 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,979,637 | 71,364 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $709,689 | 25,337 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $786,788 | 25,137 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $649,610 | 23,044 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $702,086 | 26,869 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $585,939 | 26,240 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $778,085 | 26,119 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $690,874 | 26,259 | Shares | Sole | 2022-08-25 | |
| 2021-12-31 | $656,653 | 28,231 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $880,050 | 28,536 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $742,808 | 30,294 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $342,423 | 18,331 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $391,578 | 19,628 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $381,037 | 19,631 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $482,276 | 33,445 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||